There has been enormous interest in the natural language processing (NLP) model called ChatGPT. The program generates gracefully written responses on any given topic. The advent of such chatbots have, however, also generated astonishment and worry about what this technology might bring. Many are wondering how AI and ChatGPT could be used in pharmacy. Lars-Åke Söderlund, FIP vice president & co-chair of the FIP Technology Advisory Group, and his fellow co-chair Jaime Acosta Gomez, secretary of the FIP Community Pharmacy Section interviewed ChatGPT itself to find out! We publish the unedited chat.

Carwen Wynne Howells reports on a session during FIP’s 81st World Congress of Pharmacy and Pharmaceutical Sciences, about the new experience of community pharmacy through the metaverse.

A FIP congress session in Seville, Spain, discussed ways to combat the dangers of exposure to hazardous drugs and the challenges associated with nanomedicines. Rúben Viegas reports. 

A FIP 80th World Congress of Pharmacy and Pharmaceutical Sciences session aimed to provide different perspectives on how the COVID-19 pandemic has impacted the scope of services provided by pharmacists in different settings. Alison Ubong Etukakpan reports.

Contents include:

• Continuing to deliver during a pandemic: The acceleration of “virtual” practice
• How pharmacists can transform their practice around the air pollution
• Interview with André Bédat 2020 awardee and pharmaceutical care innovator Martin Schulz
• How COVID-19 has changed the future of drug development
• How to be an agent of change for women in science and education
• Advancing cancer therapies through mathematics and trial design
• Harnessing the therapeutic potential of gut microbes
• And more reports from FIP Virtual 2020 and the 7th Pharmaceutical Sciences World Congress

Contents include: 

• Interview with Gary Kobinger, whose team developed the Ebola vaccine
  
• How COVID-19 is affecting pharmacists on front lines around the world
  
• Engaging children in medicines safety
  
• Preventing arbovirus diseases: A growing public health focus
  
• The discharge medicines review service in Wales
  
• Nine things about the WHO Immunization agenda 2030
  
• Towards patient safety through better recognition of pharmacists in Ecuador
  

• Preview of imminent OECD findings on primary health care
• Interview with Meindert Danhof, the founding father of pharmacological models
• Pharmacists combating tick-borne encephalitis
• Addressing the challenge of remuneration and sustainability of services
• Door opens to broader primary care role for community pharmacists in France
• Harnessing the science of prediction for better patient care
• How to disrupt, innovate and create value for your faculty
• Links being drawn between AMR and environmental pollution
• Research to protect patients from impurities in medicines
• Making a difference in Yemen

• How mHealth applications are improving the quality of primary health care services
• How emerging vaccine technologies are pushing disease prevention boundaries
• Evidence supports development of a pharmacy service to screen children for hypercholesterolaemia
• Pharmacists beating non-communicable diseases in the community
• Interview with Sandra Carey, global president at McCann Health Global Pharmacy
• Strengthening the role of pharmacists in primary health care in Turkey
• How Indonesia’s pharmacists are developing their primary healthcare workforce
• How US medical practices are integrating more pharmacists into primary healthcare teams
• Thoughts from Fred Mayer, the USA’s “father of public health pharmacy”
• Why we must encourage people to become active managers of their own health
• Reports from the FIP Regional Conference for the Middle Eastern Region

Content includes:

• Pharmacy “Amazonified”: What it could mean. 
• FIP’s new president on modernisation. 
• How nanotechnology breakthroughs are transforming cancer care.
• Is antibiotic stewardship always effective?
• Simplification: The WHO approach to eliminating hepatis C.
• Pharmacogenetics services from community pharmacies.
• How avatars can help improve counselling skills.
• Conflict management: Take the offensive.
• How to develop a strategic perspective for your faculty.

Contents include: 

• How pharmacists can improve adherence in the elderly. 
• Tackling dementia: New drugs, new approaches, new hope. 
• Long-term care: Optimising outcomes and being versatile. 
• How pharmacies are helping to create age-friendly communities. 
• Equipping health systems for 2030 and beyond. 
• Ensuring health and happiness for Finland’s ageing

Contents include:

• Lebanon: Pharmacists have huge potential in the refugee crisis but must act now
• World Congress of Pharmacy and Pharmaceutical Sciences reports
• Neurological disease and cancer drugs are “hot” but scientists must consider market forces
• Are you ready for Generation C?
• Medicines shortages: What progress has been made?
• Good enough is dead! Technology must be integrated into pharmacy education

Contents include:

• “End-to-end thinking” is paving the way to future medicines
• Non-profit pharma companies offering a new route to medicines
• Interview Hiroaki Kitano: Systems biology is changing health care
• Pharmaceutical Sciences World Congress reports
• Developing a postgraduate course in global pharmacy
• U-turn in Israel recognises pharmacists’ value

Contents include:

• Achieving responsible use of antimicrobial medicines
• Rising to the challenge of reducing the global burden of disease
• Stemming the tide of dementia in science
• Nalfurafine: The first non-addictive opioid agonist
• Regulatory approaches accelerate access to medicines
• Health care education and labour markets must change

Contents include:

• Interview Jim Campbell: No health without a workforce — a plan for the world
• Continuous manufacturing: What does it mean for the pharmaceutical workforce?
• Are pharmacists happy with their work?
• Free movement of pharmacists in Europe: Regulation and impact
• Brain drain/Brain gain: We need better intelligence
• Building professional capacity in Ethiopia

Contents include:

• Leading pharmacies in complex and uncertain times 
• Epigenetics is providing exciting targets for future medicines
• Look beyond your immediate community: practise in low-resource and emergency settings
• Global issues forge the path for global pharmacy citizens to follow
• Social responsibility should be part of business as usual
• Pharmacy and advocacy the Swiss way

Contents include:

• Interview Lee Vermeulen: Inspiring developments in hospital pharmacy through international standards
• World Congress of Pharmacy and Pharmaceutical Sciences reports
• New omega-3-related compound kills breast cancer cells with little sign of side effects
• Pharmacists have proved essential in the Ebola crises
• New technologies to track compliance and administration
• Increasing responsibilities of technicians need to be acknowledged

Contents include:

• Getting practical: the FIP project giving students much needed lab experience
• Crowd power being applied to research
• New pharmacy services and better care for patients with multiple sclerosis
• How real-world data are improving access to medicines
• What might be the quickest path to equip hospital pharmacists for the information age?
• ​Big data and the pharmacist — caution advised

Contents include:

• Interview Otmar Kloiber: Together we can prove our value better 
• Partnerships developing treatments: tips for success
• Developing markets where pharmacists are seen as part of the team
• Patient partnerships giving future pharmacists better skills
• Advanced pharmacy practice — the US landscape Healthcare for nomads and other challenges

Contents include:

• Interview with Carmen Peña Professional obligation: An oath for pharmacists
• World Congress of Pharmacy and Pharmaceutical Sciences reports
• HIV/AIDS, tuberculosis and Fabry disease: how shortages affect patients
• Scientists join public-private partnership to advance regulatory process
• Pharmacy bodies could take a greater role in assuring GPP
• Bright future for pharmacists in industry but no job entitlement

Contents include:

• How virtual R&D is leading to treatments for neglected diseases
• Getting drugs to the brain using modified nanocarriers
• Could we be dispensing alendronate patches in future?
• Quality by design means linking the lab to the patient early on
• How genomics can enhance drug therapy
• What Asia needs to do to foster pharmaceutical sciences

Contents include:

• Pharmacy practice in daily life Complexity everywhere?
• World Congress of Pharmacy and Pharmaceutical Sciences reports
• The Basel Statements: Where are we now?
• Managing mentally ill patients: The Role of the Pharmacist
• Better quality pharmacy education produces better pharmacists
• Pharmaceutical sciences: Approaching the Future in Drug Delivery

Contents include:

• How I hope to give back to the world by being a pharmacist
• The journey thus far: pharmacy practice across continent
• Developing medicines that are suitable for use by children
• Providing preventative care services in a community pharmacy
• Battling the tuberculosis pandemic in India
• Never stop investing in yourself, never stop learning

Contents include:

• Ensuring more responsible use of medicines: A report from the FIP stakeholders roundtables
• Improving the responsible use of OTC products
• Economics of pharmacy
• Increased legal, social, and professional accountability
• Traditional process vs. innovative practice
• Past and future impact of drug development on healthcare

Contents include:

• Global pharmacy education: Are we nearly there yet?
• New challenges in Russia: Education responds to industry
• Compounding in Brazil: Legal compliance for future progress
• Change in community pharmacy policy: How are we creating it in Taiwan?
• Team based care: Starting with the pharmacy team
• Generating care: improving adherence through pharmacy practice

Contents include:

• Global reporting initiative: Reporting sustainability sector by sector
• Decreased cost via increased access: A technology solution for sustainability
• Rebuilding pharmaceutical systems in Afghanistan
• Pharmaceutical systems development in sub-Saharan Africa: a call to action
• The FIP Young Pharmacists Group supporting sustainability
• The Amsterdam declaration: Creating a sustainable future at the FIP centennial congress

Contents include:

• World Congress of Pharmacy and Pharmaceutical Sciences reports
• A reason to change Flushing our future Counterfeits
• The magic of networking Recollections of a first timer

Contents include:

• Paediatric HIV/AIDS drug formulation development: A cost reducing strategy
• Fighting disease with attitude: Changing attitudes and behaviours about medicines in
• Paraguay Crisis management: Legal ramifications for pharmacy practice in the face of disaster
• A rising killer: Non-communicable diseases in development countries
• Looking outward and forward: Fighting neglected disease with pharmaceutical sciences
• Neglected diseases: A public health problem of low and middle-income countries only?
• A perspective from Mexico

Contents include:

• Hands off medicines enabling good dispensing practices
• Empowering patient minority populations self-medication management program for adult patients in custody
• ​The value of pharmaceutical innovation global versus Indian prospective
• Culture cross, minds meet: Uniting global scientists, highlighting pharmaceutical innovations at the
• Pharmaceutical Sciences World Congress 2010
• Broadening the vision: Expanding pharmacy education across borders
• Innovation in education: Using the national science festival in
• South Africa to raise awareness of the prevention of chronic diseases

Contents include:

• Leading FIP into the future: Dr Michel Buchmann
• Counterfeiting high on agendas Increased responsibility: The changing role of pharmacists
• The FIP Academic Institutional Membership: Aiming high at the inaugural deans’ forum
• Telepharmacy: bridging the pharmacy services gap in rural and underserviced areas
• Learning to teach: Workshop report

Contents include:

• Making a difference: Pharmacists on the headline
• Infectious disease: pharmacists involvement in medically-related global activities
• Education and patient outcomes: A call for a needs-based approach
• Continuing professional development in pharmacy practice: Is it really about learning to learn or legislating learning?
• ​Practice, progression and regulation: Widening the discussion

Contents include:

• The rise of interdisciplinary approaches: How scientists are working together for international development 
• Collaborative care of pediatric oncology patients: Focus on the pharmacy team
• Collaborative development of a health system-focused cardiology elective: Bringing a practice site into the classroom
• How to get together: A collaborative help network
• The light at the end of the tunnel? A hopeful beginning for a malaria vaccine
• Genomics in the development of vaccines

Content includes: 

• Reengineering Pharmacy Practice in a Changing World
• Cancers in Developing Countries
• Look how far we’ve come, or have we?
• Competence in the Global Pharmacy Workforce
• Responsibility for Patient Outcomes: Are You Ready?

Content includes: 

• Industrial Manufacturing in 2020
• Chronopharmaceutics
• Global Conference on the Future of Hospital Pharmacy
• Historical non-involvement and future opportunities
• Interprofessional collaboration as a catalyst for change

Content includes: 

• Evidence: Measurable, Tangible and Powerful
• Stopping the Most Avoidable Risk
• A Comprehensive Future
• The Future of Pharmacy
• It Will Never Happen To Me. But It Could

Content includes: 

FIP and WHO Establish the Pharmacy Education Taskforce
Pharmacy Education in Finland
Pharmacy Students are moving on – but how was the Journey?
23 Hard Questions for Pharmacy Educators
Dr Kamal K Midha Addresses the Pharmaceutical Sciences World Congress 2007